ArticleFrontiers in immunology2025

Immunoproteasome components LMP2, PSME1, and PSME2 as novel tissue biomarkers predicting response and survival in neoadjuvant chemoimmunotherapy for resectable NSCLC.

Ru Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.